Details for New Drug Application (NDA): 202733
✉ Email this page to a colleague
The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 202733
Tradename: | HEPARIN SODIUM |
Applicant: | Shenzhen Techdow |
Ingredient: | heparin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 202733
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 202733 | ANDA | McKesson Corporation dba SKY Packaging | 63739-901 | 63739-901-28 | 25 VIAL, MULTI-DOSE in 1 CARTON (63739-901-28) / 10 mL in 1 VIAL, MULTI-DOSE (63739-901-14) |
HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 202733 | ANDA | Hepalink USA Inc. | 81952-114 | 81952-114-09 | 25 VIAL, MULTI-DOSE in 1 CARTON (81952-114-09) / 10 mL in 1 VIAL, MULTI-DOSE (81952-114-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5,000 UNITS/ML | ||||
Approval Date: | Jun 12, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription